Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. Fazio S, Linton MF (2005) Circulation 111: 3349-51 Metabolite profiling identifies pathways associated with metabolic risk in humans. Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, Palma MJ, Roberts LD, Dejam A, Souza AL, Deik AA, Magnusson M, Fox CS, O'Donnell CJ, Vasan RS, Melander O, Clish CB, Gerszten RE, Wang TJ (2012) Circulation 125: 2222-31 Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V (2012) J Am Coll Cardiol 60: 2372-9 Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistin. Fazio S, Linton MF (2012) J Am Coll Cardiol 59: 1706-8 Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, Yang E, Farrell L, Fox CS, O'Donnell CJ, Carr SA, Vasan RS, Florez JC, Clish CB, Wang TJ, Gerszten RE (2011) J Clin Invest 121: 1402-11 Kidney function is associated with an altered protein composition of high-density lipoprotein. Rubinow KB, Henderson CM, Robinson-Cohen C, Himmelfarb J, de Boer IH, Vaisar T, Kestenbaum B, Hoofnagle AN (2017) Kidney Int 92: 1526-1535 Prepregnancy lipids related to preterm birth risk: the coronary artery risk development in young adults study. Catov JM, Ness RB, Wellons MF, Jacobs DR, Roberts JM, Gunderson EP (2010) J Clin Endocrinol Metab 95: 3711-8 The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis. Jensky NE, Hyder JA, Allison MA, Wong N, Aboyans V, Blumenthal RS, Schreiner P, Carr JJ, Wassel CL, Ix JH, Criqui MH (2011) J Bone Miner Res 26: 2702-9 High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome. Wilke RA (2011) Pharmacogenomics J 11: 162-73 The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy. Feng Q, Wei WQ, Chung CP, Levinson RT, Bastarache L, Denny JC, Stein CM (2017) Pharmacogenomics J 17: 204-208 Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K (2011) Obstet Gynecol 117: 6-13 Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice. Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH (2008) Am J Physiol Endocrinol Metab 294: E284-90 Natural killer T cells and atherosclerosis: form and function meet pathogenesis. Braun NA, Covarrubias R, Major AS (2010) J Innate Immun 2: 316-24 Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice. Murali G, Milne GL, Webb CD, Stewart AB, McMillan RP, Lyle BC, Hulver MW, Saraswathi V (2012) J Lipid Res 53: 2186-97 AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Viollet B, Guigas B, Leclerc J, Hébrard S, Lantier L, Mounier R, Andreelli F, Foretz M (2009) Acta Physiol (Oxf) 196: 81-98 Nonpharmacologic treatment of dyslipidemia. Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, Bramlet DA (2009) Prog Cardiovasc Dis 52: 61-94 Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia. Ali YS, Linton MF, Fazio S (2008) Curr Opin Endocrinol Diabetes Obes 15: 142-6 Importance of high-density lipoprotein quality: evidence from chronic kidney disease. Kon V, Ikizler TA, Fazio S (2013) Curr Opin Nephrol Hypertens 22: 259-65 Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Yamamoto S, Kon V (2009) Curr Opin Nephrol Hypertens 18: 181-8 Adropin deficiency is associated with increased adiposity and insulin resistance. Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, Culler MD, Mynatt RL, Butler AA (2012) Obesity (Silver Spring) 20: 1394-402 A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers. Albaugh VL, Singareddy R, Mauger D, Lynch CJ (2011) PLoS One 6: e22662 A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain. Feng Q, Jiang L, Berg RL, Antonik M, MacKinney E, Gunnell-Santoro J, McCarty CA, Wilke RA (2010) PLoS One 5: e15779 NOS3 gene polymorphisms are associated with risk markers of cardiovascular disease, and interact with omega-3 polyunsaturated fatty acids. Ferguson JF, Phillips CM, McMonagle J, Pérez-Martínez P, Shaw DI, Lovegrove JA, Helal O, Defoort C, Gjelstad IM, Drevon CA, Blaak EE, Saris WH, Leszczyńska-Gołabek I, Kiec-Wilk B, Risérus U, Karlström B, Lopez-Miranda J, Roche HM (2010) Atherosclerosis 211: 539-44 Dietary chickpeas reverse visceral adiposity, dyslipidaemia and insulin resistance in rats induced by a chronic high-fat diet. Yang Y, Zhou L, Gu Y, Zhang Y, Tang J, Li F, Shang W, Jiang B, Yue X, Chen M (2007) Br J Nutr 98: 720-6 Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia. Gutierrez DA, Puglisi MJ, Hasty AH (2009) Curr Diab Rep 9: 26-32 Mechanisms of progression of chronic kidney disease. Fogo AB (2007) Pediatr Nephrol 22: 2011-22 Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Kurtz CL, Fannin EE, Toth CL, Pearson DS, Vickers KC, Sethupathy P (2015) Sci Rep 5: 12911 The effect of incident antidiabetic regimens on lipid profiles in veterans with type 2 diabetes: a retrospective cohort. Roumie CL, Huizinga MM, Liu X, Greevy RA, Grijalva CG, Murff HJ, Hung AM, Griffin MR (2011) Pharmacoepidemiol Drug Saf 20: 36-44 PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia. Jiang M, Strand DW, Franco OE, Clark PE, Hayward SW (2011) Differentiation 82: 220-36 Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice. Braun Na, Wade NS, Wakeland EK, Major AS (2008) Lupus 17: 1070-8 Increased oxidative stress and altered substrate metabolism in obese children. Oliver SR, Rosa JS, Milne GL, Pontello AM, Borntrager HL, Heydari S, Galassetti PR (2010) Int J Pediatr Obes 5: 436-44 The cumulative effect of core lifestyle behaviours on the prevalence of hypertension and dyslipidemia. Villegas R, Kearney PM, Perry IJ (2008) BMC Public Health 8: 210 Long-term management of the kidney transplant recipient. Schaefer HM (2012) Blood Purif 33: 205-11 Basal insulin: beyond glycemia. Niswender KD (2011) Postgrad Med 123: 27-37 Oral retinoids and plasma lipids. Lilley JS, Linton MF, Fazio S (2013) Dermatol Ther 26: 404-10 Dyslipidemias in children. Lilley JS, Linton MF, Fazio S (2012) Pediatr Ann 41: e1-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.